Our findings are in line with the observations of Sozer [25] and Rosti [21], while differ from Teofili’s study, in which the JAK2 positive ECFCs were described only in a subset of patients with thrombosis [23]. This evidence concerns the gene JAK2 and deep vein thrombosis.